
Now, Leo Pharma can get properly started on launching the drug Adtralza in the EU.
Tuesday, the EU Commission ratified the former recommendation for approval, which the Committee for Medicinal Products for Human Use (CHMP) gave Adtralza in April, according to a press release from the company.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app